Dec 20, 2017
This episode discusses how, in order to maintain a flow of innovative medicines there is a growing realisation that companies cannot allow the status quo to remain as it is and the need to identify sources of appropriate knowledge and expertise outside of their own organisations is paramount. This episode discusses some of the challenges in arranging collaborative arrangements in pharma with each other and academia.
Please note that as this article is from 2014 some statistics etc may now be incorrect, however as one of the most popular articles on the DDW site, we still think it’s extremely relevant today.
The original article this episode is based on was written by Professor Jackie Hunter. If you'd like to view the original article then follow the link below:
You can also download the original article pdf here: